Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

  • This share is currently suspended. It was suspended at a price of 2.45
  • There is currently no data for AGFX

Board Changes

6 May 2025 07:12

RNS Number : 4359H
Argentex Group PLC
06 May 2025
 

6 May 2025

 

Argentex Group plc

("Argentex" or the "Company")

 

Board Changes

 

Argentex Group PLC (AIM: AGFX) announces that, following the 25 April 2025 announcement regarding the recommended acquisition of Argentex by IFX Payments, the directors had reviewed the composition of the board and agreed that it would be in the best interests of the Company and its shareholders to reduce the number of directors. Accordingly, each of Henry Beckwith, Lord Digby Jones, Rina Ladva and Jeff Parker (all non-executive directors of the Company) agreed to resign and left the board on Friday 2 May 2025.

 

In addition, Guy Rudolph, the Company's Chief Financial Officer, on Friday 2 May 2025 notified the board of his resignation. Guy will continue to serve as Chief Financial Offer of the Company whilst he serves out his notice period of 6 months.

 

Following the completion of statutory Due Diligence checks, Tim Rudman was formally appointed to the board on 5 May 2025.

 

Following Tim's appointment the board now consists of Nigel Railton, non-executive chairman, Jonathan Gray, senior independent non-executive director, Tim Haldenby, independent non-executive director and Tim Rudman as Chief Executive Officer.

 

Nigel Railton, Chairman of Argentex said:

 

"Against the background of an extremely challenging past few weeks for Argentex, I would like to thank Henry, Lord Digby, Rina and Jeff for their expertise and contribution to Argentex during their tenure with the Company. Each of their experiences have provided valuable perspective for both the board and the wider group. We wish each of them well for the future."

 

For further information, please contact:

 

Argentex Group PLC

Tim Rudman - Interim Chief Executive Officer

investorrelations@argentex.com

 

Teneo (Financial PR)

James Macey-White/Victoria Boxall/ Riann Cato

argentex@teneo.com, 020 7260 2700

 

Singer Capital Markets (Financial Adviser, Nominated Adviser and Broker)

Tom Salvesen / James Maxwell / James Todd

020 7496 3000

 

Disclosure under Schedule 2(g) of the AIM Rules for Companies

 

Timothy James Rudman, aged 41, holds/has held the following directorships in the last five years:

 

Current Directorships / Partnerships

Previous Directorships / Partnerships

· N/A

· Foreign Currency Exchange Limited

· Global Reach Partners Limited

· Rudman Capital Ventures LTD

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPKPBBDBKBPPK
Date   Source Headline
26th Oct 20237:00 amRNSBoard Change
13th Sep 20237:00 amRNSInterim results for the six months to 30 June 2023
19th Jul 20232:36 pmRNSTR1 Disclosure - Gresham House Asset Management
18th Jul 20237:00 amRNSNotice of Interim Results
12th Jul 202312:55 pmRNSDirector / PDMR Dealing
10th Jul 20237:00 amRNSHalf year trading update and board changes
27th Jun 202312:20 pmRNSTR1 Notification
22nd Jun 20239:46 amRNSResult of AGM
20th Apr 20235:05 pmRNSPublication of Annual Report and Notice of AGM
12th Apr 20237:00 amRNSFull results for the 9 months to 31 December 2022
30th Mar 20237:00 amRNSNotice of Results and Presentations
13th Mar 20237:00 amRNSUpdate on counterparties
28th Feb 20237:00 amRNSBoard Announcement
26th Jan 20237:00 amRNSTrading Statement
12th Dec 20227:00 amRNSTrading Statement
17th Nov 20222:08 pmRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSGrant of Awards Under New LTIP
8th Nov 202212:55 pmRNSNew Long Term Incentive Plan
8th Nov 20227:00 amRNSInterim Results
12th Oct 20227:00 amRNSNotice of Interim Results
3rd Oct 20227:00 amRNSTrading Update
23rd Sep 20226:05 pmRNSHolding(s) in Company
16th Sep 20227:00 amRNSNetherlands Electronic Money Licence granted
9th Sep 20221:10 pmRNSHolding(s) in Company
22nd Aug 20221:59 pmRNSResult of AGM
15th Jul 20227:00 amRNSPublication of Annual Report and Notice of AGM
6th Jul 20227:00 amRNSFull year results for period ended 31 March 2022
31st May 20227:00 amRNSNotice of Results
12th Apr 20227:00 amRNSTrading Update
8th Nov 20217:00 amRNSInterim Results
1st Nov 20217:00 amRNSInterim Results Presentations
11th Oct 20217:00 amRNSTrading Statement
27th Aug 20215:21 pmRNSHolding(s) in Company
13th Aug 20212:16 pmRNSHolding(s) in Company
12th Aug 20214:09 pmRNSHolding(s) in Company
12th Aug 20213:09 pmRNSHolding(s) in Company
12th Aug 20213:08 pmRNSHolding(s) in Company
11th Aug 20211:08 pmRNSHolding(s) in Company
11th Aug 20219:41 amRNSDirector/PDMR Shareholding
4th Aug 20216:08 pmRNSResult of AGM
29th Jul 20217:00 amRNSChange to AGM Arrangements
13th Jul 202112:04 pmRNSHolding(s) in Company
12th Jul 20217:00 amRNSPublication of Annual Report and Notice of AGM
5th Jul 20212:22 pmRNSHolding(s) in Company
1st Jul 20217:00 amRNSFull year results for period ending 31 March 2021
22nd Jun 20217:00 amRNSNotice of Results
11th Jun 20217:00 amRNSDirectorate Change
10th May 20217:00 amRNSManagement team update
12th Apr 20218:00 amRNSExtension of audit partner's tenure & audit tender
6th Apr 20217:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.